The efficacy and safety of paclitaxel and carboplatin with versus without bevacizumab in patients with non-small-cell lung cancer: a systematic review and meta-analysis

OBJECTIVES: To investigate the efficacy and safety of Bevacizumab (Bev) used in combination with paclitaxel and carboplatin (PC), compared with PC alone in patients with advanced non-small-cell lung cancer (NSCLC). MATERIALS AND METHODS: We searched the PubMed, EMBASE, Cochrane Central Register of C...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Oncotarget
Main Authors: Han, Shiqian, Hong, Yuanduo, Liu, Tingting, Wu, Na, Ye, Zhijia
Format: Artigo
Jezik:Inglês
Izdano: Impact Journals LLC 2017
Teme:
Meta-Analysis
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5865694/
https://ncbi.nlm.nih.gov/pubmed/29581868
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.23657
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki